Name: Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons (Video) | JoVE Journal
Uploaded: 2025-06-06T13:15:00.000+00:00
Duration: 8 min 4 s
Description: Explore a multiscale framework to analyze GABA A receptor mutations in CA1 pyramidal neurons. This method helps researchers understand how pathogenic variants affect neuronal excitability and epilepsy mechanisms.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

We thank &#199;a&#287;la Koca for her assistance with the construction of the model neuron.

All authors declare that they have no conflicts of interest related to this work.

By applying a combination of computational genetics, molecular modeling and neural simulations, the approach presented in this paper has the potential to improve the classification of GABAA receptor variants, offering valuable insights for both epilepsy research and clinical applications. A comprehensive analysis for the identification and prioritization of predicted pathogenic mutations is presented and extended into a framework that potentially bridges the gap between variant effects on protein and cellular ...

For nearly all human diseases, genetic variation plays a significant role in individual susceptibility. Therefore, understanding how sequence variations relate to disease risk offers a valuable way to uncover key processes involved in disease development and identify new approaches for prevention and treatment1. This also applies to neurodevelopmental disorders, which rank among the most prevalent chronic medical conditions in pediatric primary care2. Conditions such as autism spectrum disorder, intellectual disability, and epilepsy illustrate how genetic variation significantly influences individual susceptibility during development3.
The developing brain is more susceptible to epileptic seizures than the adult brain due to genetically programmed neurodevelopmental mismatch in the critical balance between excitation and inhibition4. As GABA (gamma-aminobutyric acid), the primary inhibitory neurotransmitter in the adult brain, is excitatory during embryonic and early postnatal development, this is not favorable to the stability needed to prevent seizures in young brains. This temporary state, caused by the lack of sufficient expression of K-Cl co-transporters5, can contribute to an increased risk of seizure activity in the presence of dysfunctional GABAA receptors. GABAA receptors mediate excitatory and inhibitory actions of GABA, depending on the intracellular concentration of the Cl- ion6. Thus, as the brain matures, mutations in the GABAA receptor-encoding genes, as well as in other ion channels, distort excitability, and mutations in genes involved in neuronal metabolism, cell signaling, and synapse formation7, can cause conditions like childhood absence epilepsy8.
Clinical interventions are increasingly leveraging genetic analysis to improve precision in treating neurodevelopmental disorders2. Genetic testing in pediatric epilepsy presents potential targets for precision medicine approaches9, highlighting the significance of genetic variants in guiding treatment decisions. In addition, ~25% of epilepsy patients with de novo mutations receive genetic diagnoses that identify potential targets for precision medicine, underscoring the significant value of genetic variants in guiding treatment decisions10. This has been fueled by advancements in next-generation sequencing technologies, such as targeted gene panels, whole-exome sequencing, and whole-genome sequencing, which have dramatically accelerated genetic discoveries11. However, the increasing number of new gene discoveries comes with a challenge when results yield a variant of unknown significance (VUS), a classification that reflects conflicting evidence or insufficient information regarding the variant&#39;s molecular role in disease pathogenesis. Variants classified as VUS correspond to one category within the five-tier variant classification system proposed by the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP)12.
Addressing the challenge of functionally unknown genetic variants requires efforts across two key dimensions: clinical practice and research. Clinically, the uncertainty surrounding VUS can complicate patient management and decision-making13. From a scientific research perspective, identifying pathogenic variants among the increasing number of variants of uncertain significance and determining their roles in disease pathophysiology and phenotypic effects are crucial1. One ideal scenario would involve accurately predicting the molecular, neuronal, and network-level effects of all functionally uncharacterized variants, thereby minimizing the resources, time, and effort required for laboratory-based investigations. These aspects underscore the importance of accurately classifying genetic variants to enable precise diagnosis of genetic epilepsies, support personalized treatment, and facilitate the discovery of potential pharmacological targets. Current predictive tools14,15,16,17 are relatively accurate but typically provide only binary classifications (pathogenic vs. benign) and lack disease-specific insights into molecular pathophysiology, phenotypic consequences, and underlying mechanisms. Focusing on the unknown missense variants of selected GABAA receptor subunit-encoding genes, this paper presents a framework aimed at enhancing research guidance by incorporating contextual factors of variants such as molecular, evolutionary, and structural aspects, as well as simulations of neural pathology derived from in vitro biophysical data of epilepsy-associated mutations. Our methodology addresses the identification of unknown pathogenic variants of the &#947;2 subunit of the GABAA receptor, a key subunit involved in the pathophysiology of epilepsy18,19,20. This is followed by the exploration of position-specific matching of these predicted variants with the epilepsy-associated mutations characterized by structural and electrophysiological data. These data are then used to estimate the variant effect on a model of hippocampal pyramidal neuron expressing a GABAA receptor subtype, composed of &#947;2, &#945;1, and &#946;3 subunits (&#947;2-GABAA receptors), responsible for fast synaptic inhibition6. It is important to note that GABAA receptors assemble from a large subunit pool (&#945;1-&#945;6, &#946;1-&#946;3, &#947;1-&#947;3, &#948;, &#917;, &#952;, &#960;, and &#961;1-&#961;3) and depending on the subunit composition, GABAA receptors differ in their modulation, biophysical characteristics, as well as regional, cellular, and subcellular expression patterns coupled with specific functions6,21,22,23,24,25. Thus, the present study focuses on the &#947;2-GABAA receptors or &#947;2-containing GABAA receptors only.
GABAA receptor subunits are composed of characteristic structural features-a long N-terminal extracellular domain (ECD), four transmembrane spanning domains (TM1 to TM4), an intracellular linker connecting the TM1 and TM2, an extracellular linker connecting the TM2 and TM3, a large intracellular loop between TM3 and TM4 (TM3-TM4 loop), and a short extracellular C terminus6,26,27. It is suggested that the GABAA receptor functions via a complex &#34;lock and pull&#34; mechanism, where GABA binding locks the &#946; and &#945; subunits, causing them to pull on the extracellular domains (ECDs) of the subunits, rotating them counterclockwise27. This movement bends the transmembrane domains (TMDs), thereby opening the ion channel27. Thus, the channel activity appears to be coordinated together with structural cassettes within the GABAA receptors. It turns out that epilepsy mutations cause dysfunction in channel activity via distortion of these structural cassettes28. Consequently, our study is based on the idea that predicted pathogenic variants in proximity to functionally identified epileptogenic mutations in the specific structural cassettes of the GABAA receptor subunits may exhibit similar patterns of electrophysiological or biophysical distortion in channel function, as observed in cases of these epileptogenic mutations. While the presence of epileptogenic structural cassettes in the GABAA receptor subunits28 indirectly supports this notion, our study demonstrates the complexity and challenge of correlating biophysical parameters of epileptogenic mutations with those of predicted pathogenic mutations. To unmask these complex relationships, our framework is significant as it highlights a multiscale approach ranging from DNA to protein function and neural behavior critical for epilepsy research. This approach integrates computational genetics with molecular modeling and neural simulations while also emphasizing the importance of complementary methods, such as machine learning trained on large datasets, that could capture the effects of mutations on channel structure, activity, and neural excitability. In addition, the simulation of epileptogenic &#947;2-GABAA receptor activity on the hippocampal pyramidal neuron model allows the replication of in vitro cellular phenotype associated with GABAA receptor channelopathy and the demonstration of altered single-neuron responses at the center of network dysfunction.

<table><tbody><tr><td>Brian2&amp;nbsp;</td><td>Sorbonne Universit&amp;eacute;, INSERM, CNRS, Institut de la Vision, France; Imperial College London, United Kingdom</td><td>2.8.0.4</td><td>Stimberg et al., 2019 (https://pypi.org/project/Brian2/ )</td></tr><tr><td>dbNSFP server&amp;nbsp;&amp;nbsp;</td><td>Genos Bioinformatics LLC, USA</td><td>v3.0</td><td>Liu et al., 2020 (http://database.liulab.science/dbNSFP) (https://sites.google.com/site/jpopgen/dbNSFP)</td></tr><tr><td>HOPE&amp;nbsp;&amp;nbsp;</td><td>Centre for Molecular and Biomolecular Informatics CMBI, Radboud University, Netherlands&amp;nbsp;</td><td>1.1.1</td><td>Venselaar et al., 2010 (https://www3.cmbi.umcn.nl/hope/)</td></tr><tr><td>Jalview&amp;nbsp;&amp;nbsp;</td><td>University of Dundee, UK</td><td>JV2</td><td>Waterhouse et al., 2009 (https://www.jalview.org/)</td></tr><tr><td>Jupyter Notebook</td><td>Project Jupyter, USA</td><td></td><td>https://jupyter.org/install&amp;nbsp;</td></tr><tr><td>Phyton</td><td>Python Software Foundation, USA</td><td>3.13</td><td>https://www.python.org/downloads/</td></tr><tr><td>Protter&amp;nbsp;&amp;nbsp;</td><td>ETH Zurich, Switzerland</td><td>Version 1.0</td><td>Omasits, et al., 2014 (https://wlab.ethz.ch/protter/start/)</td></tr><tr><td>R&amp;nbsp;</td><td>The R Foundation for Statistical Computing, USA</td><td>R version 4.3.2&amp;nbsp;</td><td>&amp;nbsp;https://www.r-project.org/&amp;nbsp;</td></tr><tr><td>RStudio</td><td>Posit software, PBC, USA</td><td>RStudio 2023.12.1+402 &quot;Ocean Storm&quot; Release</td><td>https://posit.co/downloads/</td></tr></tbody></table>

identification and classification of position-specific gabaa receptor subunit missense variants for their role in hippocampal pyramidal neurons

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Understanding the effects of functionally unknown variants in epilepsy associated genes is crucial for elucidating disease pathophysiology and developing personalized therapeutics. With a multiscale framework, spanning from DNA sequence to protein function and neural behavior, we describe a novel approach for predicting and investigating pathogenic mutations, hypothesizing that epileptogenic mutations in the GABAA receptor subunit and nearby predicted mutations may produce similar effects on the CA1 pyramidal neuron model. By exploring the characteristic relationships between predicted pathogenic mutations and proximal epileptogenic mutations, the study aims to estimate the effects of predicted mutations based on the effects of epileptogenic mutations on hippocampal pyramidal neuron simulations.
The methodology begins with the collection of GABAA receptor &#947;2 subunit genetic data, followed by data cleaning and formatting performed in R using a custom script. Next, ensemble predictors will be applied to identify and prioritize the pathogenic missense variants of the &#947;2 subunit. Mapping a specific pathogenic variant (predicted) to the subunit structural domains shared by epileptogenic mutations will be illustrated, accompanied by molecular modeling of their effects and consideration of evolutionary conservation. Then, variant-specific meta-analysis and parameter normalization will be performed, followed by correlation analysis to identify any significant relationships between predicted mutations and proximal epileptogenic mutations. Using a Python-based neural simulator, multi-compartmental conductance-based neuron model, reflecting the effect of wild-type and epileptogenic mutants will be described. Simulation of neural responses generated by epileptogenic GABAA receptor subtype will be considered for the rough estimation of the predicted pathogenic variants&#39; effect on neural response. To our knowledge, this is the first protocol exploring a multiscale framework to estimate the effects of GABAA receptor variants on neuronal behavior, crucial for epilepsy research. This protocol can serve as a foundation for enhancing predictions of cellular phenotypes caused by potentially pathogenic variants of GABAA receptors associated with epilepsy.

This study utilizes a multiscale approach to predict and characterize the pathogenic variants in the γ2 subunit of the GABAA receptor, a key component in the pathophysiology of epilepsy. Through the use of predictive models, molecular modeling, evolutionary conservation, structural examination, correlation analysis, and neural simulations, this approach enhances the classification of variants, with significant relevance for epilepsy research and possibly for clinical use. The o...

This study introduces a multiscale framework, spanning from DNA to protein function and neural behavior. It presents a novel approach for investigating predicted pathogenic mutations in the GABAA receptor subunit, hypothesizing that epileptogenic mutations and proximal mutations, predicted as pathogenic, may produce similar effects on the CA1 pyramidal neuron model.

Understanding the effects of functionally unknown variants in epilepsy associated genes is crucial for elucidating disease pathophysiology and developing ...

identification-classification-position-specific-gabaa-receptor

Research

JoVE Journal

Neuroscience

Neurons are first characterized electrophysiologically. Then the cytoplasm from the recorded neuron is aspirated and subjected to reverse transcription-PCR analysis to detect the expression of mRNAs for neurotransmitter synthesis enzymes, ion channels, and receptors.

Profiling Voltage-gated Potassium Channel mRNA Expression in Nigral Neurons using Single-cell RT-PCR Techniques

Here we demonstrate the use of fluorescent Alexa dye coupled to α-bungarotoxin to measure GABA A receptor surface localization and endocytosis in hippocampal neurons. Through the use of constructs bearing a short extracellular tag that binds α-bungarotoxin, analysis of plasma membrane protein endocytic trafficking can be achieved.

Using an &#945;-Bungarotoxin Binding Site Tag to Study GABA A Receptor Membrane Localization and Trafficking

Cortical networks are controlled by a small, but diverse set of inhibitory interneurons. Functional investigation of interneurons therefore requires targeted recording and rigorous identification. Described here is a combined approach involving whole-cell recordings from single or synaptically-coupled pairs of neurons with intracellular labeling, post-hoc morphological and immunocytochemical analysis.

Whole-cell Patch-clamp Recordings from Morphologically- and Neurochemically-identified Hippocampal Interneurons

The molecular mechanisms that co-ordinate the formation of inhibitory GABAergic synapses during ontogeny are largely unknown. To study these processes,we have developed a co-culture model system which incorporates embryonic medium spiny GABAergic neurons cultured together with stably transfected human embryonic kidney 293 (HEK293) cells expressing functional GABAA receptors.

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors

Electroconvulsive seizure (ECS) is an experimental animal model of electroconvulsive therapy for severe depression. ECS globally stimulates activity in the hippocampus, leading to synaptogenesis and synaptic plasticity. Here, we describe methods for ECS induction in rats and for subcellular fractionation of their hippocampi to examine seizure-induced changes in synaptic proteins.

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

We describe the puff technique, by which pharmacological reagents can be administered during whole-cell patch-clamp recording, and highlight various aspects of the features that are crucial for its success.

Whole-cell Currents Induced by Puff Application of GABA in Brain Slices

Targeted next-generation sequencing is a time- and cost-efficient approach that is becoming increasingly popular in both disease research and clinical diagnostics. The protocol described here presents the complex workflow required for sequencing and the bioinformatics process used to identify genetic variants that contribute to disease.

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

This protocol describes the critical steps and precautions required to perform single cell multiplex reverse transcription polymerase chain reaction after patch-clamp. This technique is a simple and effective method to analyze the expression profile of a predetermined set of genes from a single cell characterized by patch-clamp recordings.

Single Cell Multiplex Reverse Transcription Polymerase Chain Reaction After Patch-clamp

Here, we present protocols to discover compounds active at GABAA receptors, from the binding to the physiology and pharmacology.

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Neuronal excitability can be modulated through a dynamic process of endo- and exocytosis of excitatory ionotropic glutamate receptors. Described here is an accessible, high-content assay for quantifying surface and internal receptor population pools.

A High-content Assay for Monitoring AMPA Receptor Trafficking

Explore a multiscale framework to analyze GABA A receptor mutations in CA1 pyramidal neurons. This method helps researchers understand how pathogenic variants affect neuronal excitability and epilepsy mechanisms.

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons (Video) | JoVE Journal

Identification and Classification of Position-specific GABA_A Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Explore More Videos